Key Highlights

● Intel was downgraded to Neutral and fell about 25% premarket on weak fourth-quarter guidance.

● Reddit drew two downgrades and was down about 21% premarket.

● Stryker was cut to Hold, with shares down about 11% premarket.

● Next week's AMD, Qualcomm and Palantir Earnings will test whether the downgrade cycle spreads.

Wall Street analysts issued a cluster of downgrades on Friday morning, many of them reacting to disappointing earnings and guidance released after Thursday's close. The calls are landing on a day when Nasdaq-100 futures were down about 2.6% and S&P 500 futures about 1.1% around 8 a.m. ET, according to market quotes.

The headline downgrades

One brokerage cut Intel (NASDAQ:INTC) to Neutral from Buy and lowered its price target to $100 from $145, according to market reports. The move followed Intel's fourth-quarter Revenue guidance of $15.0 billion to $16.0 billion, well below the consensus of $17.07 billion. Intel was down about 25% premarket, at $68.99 as of 8:23 a.m. ET according to the premarket table. Not every analyst agreed: another brokerage upgraded the stock to Outperform with a $95 target.

Reddit (NYSE:RDDT) drew two downgrades. One brokerage moved the stock to Perform from Outperform, and another cut it to Market Perform, according to market reports. The calls followed weaker-than-expected fourth-quarter revenue guidance and warnings about declining search-referral traffic. A long list of firms also slashed targets, including one to $150 from $300 and another to $140 from $215, according to market data. Reddit was down about 21% premarket at $102.82, according to market reports.

A brokerage downgraded Stryker (NYSE:SYK) to Hold from Buy and cut its target to $300 from $385. Stryker said its third quarter "did fall short of our expectations," and its updated 2026 guidance of $14.80 to $14.90 in adjusted EPS came in below the $14.95 estimate, according to market data. Shares were down about 11% premarket.

Medtech, financials and more

One brokerage downgraded Boston Scientific (NYSE:BSX) to Hold from Buy and cut its target from $56 to $46, according to market reports. Another downgraded Honeywell Aerospace (NASDAQ:HONA), the newly independent company, to Market Perform from Outperform with a $181 target; the reference price in market data was $160.04. The same brokerage also cut Alphatec (NASDAQ:ATEC) to Market Perform with an $8 target, after the stock fell about 30% after hours Thursday, according to market data.

Other downgrades included a brokerage cutting First Industrial Realty (NYSE:FR) to Neutral with a $60 target, another cutting Mortgage insurer Essent Group (NYSE:ESNT) to Neutral with a $68 target from $78, and a third moving Alignment Healthcare (NASDAQ:ALHC) to Sector Weight, according to market data. A further brokerage cut Instacart parent Maplebear (NASDAQ:CART) to Neutral after DoorDash (NASDAQ:DASH) agreed to buy it at $65 a share. Another firm downgraded Bicara Therapeutics (NASDAQ:BCAX) to Sell with an $8 target, and a research house downgraded F5 (NASDAQ:FFIV) to Hold from Strong Buy.

Why it matters and what to watch

Intel, Stryker and Boston Scientific are S&P 500 members, so the pressure feeds directly into the benchmark. Downgrades after a guidance miss can extend selling pressure because some institutional investors follow rating changes closely. They also reflect a broader theme this earnings season: investors are punishing weak outlooks harshly even when quarterly results beat. Market data as of Oct. 23 showed 83% of reporting S&P 500 companies beating EPS estimates, but with an aggregate surprise of just 2.1%, below the five-year average of 7.5%.

Downgrades often arrive after the bad news is already priced in. Many of these stocks had fallen sharply before the notes came out, and contrarian investors sometimes view clusters of downgrades as a sign of capitulation. One brokerage, for example, called Intel a "Battleground Stock," according to a headline.

Watch whether downgraded names find buyers after the 9:30 a.m. ET open or extend their declines. More target revisions are likely through the day, and next week's earnings from AMD (NASDAQ:AMD), Qualcomm (NASDAQ:QCOM) and Palantir (NASDAQ:PLTR) will test whether the downgrade cycle spreads.